PYRROLOPYRAZOLDERIVATE
DE602020049153T2Active Publication Date: 2025-04-09DAIICHI SANKYO CO LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- DE602020049153
- Authority / Receiving Office
- DE · DE
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2020-03-05
- Publication Date
- 2025-04-09
- Estimated Expiration
- 2040-03-05
AI Technical Summary
Technical Problem
Current treatments for cancer with suppressed phosphatidylserine synthase 2 (PSS2) function are limited, and there is a need for effective inhibitors of phosphatidylserine synthase 1 (PSS1) to target such cancers.
Method used
A new low molecular compound with a specific structure is identified, which acts as a PSS1 inhibitor, offering potential as a medicament for treating cancers with suppressed PSS2 function.
Benefits of technology
The compound effectively inhibits PSS1, providing a therapeutic approach for cancers with suppressed PSS2 function, including various types such as testicular germ cell tumor, ovarian cancer, and lung cancer.
✦ Generated by Eureka AI based on patent content.
Need to check novelty before this filing date? Find Prior Art
No text content released.